FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
Open Access
- 18 January 2021
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 28 (6) , 1837-1848
Abstract
Ubiquitination by serving as a major degradation signal of proteins, but also by controlling protein functioning and localization, plays critical roles in most key cellular processes. Here, we show that MITF, the master transcription factor in melanocytes, controls ubiquitination in melanoma cells. We identified FBXO32, a component of the SCF E3 ligase complex as a new MITF target gene. FBXO32 favors melanoma cell migration, proliferation, and tumor development in vivo. Transcriptomic analysis shows that FBXO32 knockdown induces a global change in melanoma gene expression profile. These include the inhibition of CDK6 in agreement with an inhibition of cell proliferation and invasion upon FBXO32 silencing. Furthermore, proteomic analysis identifies SMARC4, a component of the chromatin remodeling complexes BAF/PBAF, as a FBXO32 partner. FBXO32 and SMARCA4 co-localize at loci regulated by FBXO32, such as CDK6 suggesting that FBXO32 controls transcription through the regulation of chromatin remodeling complex activity. FBXO32 and SMARCA4 are the components of a molecular cascade, linking MITF to epigenetics, in melanoma cells.Keywords
This publication has 34 references indexed in Scilit:
- EMT and Cancer: More Than Meets the EyeDevelopmental Cell, 2019
- Ubiquitin ligases in oncogenic transformation and cancer therapyNature Reviews Cancer, 2017
- FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain developmentNature Communications, 2017
- SF3B1 and BAP1 mutations in blue nevus-like melanomaLaboratory Investigation, 2017
- FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradationOncogene, 2017
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaCell, 2016
- PARKINInactivation Links Parkinson’s Disease to MelanomaJNCI: Journal of the National Cancer Institute, 2015
- New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific AnalysisCell Reports, 2015
- Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cellseLife, 2015
- Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progenyOncogene, 2011